PubMed Health⌕ Search

Biomedical subjects

C Battu

Publications and source records attributed to C Battu.

2 recordsLinked to original sources

Screening procedure for 21 amphetamine-related compounds in urine using solid-phase microextraction and gas chromatography-mass spectrometry.

A specific, sensitive, and rapid procedure for the screening of 21 amphetamine-related compounds in urine is developed using solid-phase microextraction (SPME) and gas chromatography-mass spectrometry. Very clean extracts are obtained in one step with SPME using silica fibers coated with a 100-micron polydimethylsiloxane stationary phase. Temperature, time, pH, and salt saturation are optimized to obtain consistent extraction. An excellent chromatographic separation of the underivatized analytes is obtained with a specially treated nonpolar capillary column (Supelco PTA-5, 30 m x 0.32-mm i.d., 0.5-micron film thickness) dedicated to amino compounds. Selected ion monitoring of three fragments per analyte and one for each of the three deuterated internal standards elicits a high selectivity and detection limits between 1 and 50 ng/mL (i.e., low enough to verify positive results obtained with immunochemical assays). The method is linear in a narrow range (from the detection limit up to 500 ng/mL) when all the amphetamines are assayed together but shows a good linearity up to 2000 ng/mL when the molecules are determined individually. Repeatability is not satisfactory for all compounds but could probably be improved by strictly controlling the extraction time (e.g., by automating the whole procedure using an autosampler). The use of SPME reduces the interference due to urinary low-volatility organic compounds and avoids the risks related to the use of organic solvents. To our knowledge, this technique is the first one allowing the sensitive determination of such a number of amphetamine analogs.

Amphetamine↗

Simultaneous determination of amphetamine and its analogs in human whole blood by gas chromatography-mass spectrometry.

A sensitive and specific gas chromatography-mass spectrometry (GC-MS) method for the determination of amphetamine (AM), methamphetamine (MA), methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA) and methylenedioxyethylamphetamine (MDEA) in whole blood was designed, using the respective pentadeuterated analogs of the analytes as internal standards (I.S.). After alkalinisation of blood samples, the amphetamines were extracted using diethyl ether, derivatized with heptafluorobutyric anhydride, then purified by successive washings with deionized water and 4% NH4OH. Extraction recoveries were 85.2% for AM, 90.9% for MA, 76.5% for MDA, 84.1% for MDMA and 63.6% for MDEA. Chromatographic separation was performed on a non-polar 30 m x 0.32 mm HP 5 MS capillary column using a temperature program. Detection was carried out in the electron-impact, selected ion-monitoring mode, using three mass-to-charge ratios for each analyte and one for each I.S. Limits of detection ranged from 0.5 to 8 ng/ml and limits of quantification were 10 ng/ml for AM, MDMA and MDEA; 20 ng/ml for MA; and 50 ng/ml for MDA. The method was linear from this limit up to 1000 ng/ml for all analytes, with good intra-assay precision and good intermediate precision and accuracy over these ranges. There was no interferences from other sympathomimetic drugs such as ephedrine, norephedrine or methoxyphenamine. This method is thus suitable for clinical and forensic toxicology, as well as for doping control.

Amphetamines↗